Skip to content

How often do you take Humira for Crohn's? Understanding the schedule

4 min read

Humira (adalimumab) is a treatment option for moderate to severe Crohn's disease. Its administration schedule is carefully designed and typically involves an initial period with more frequent injections, followed by a regular, less frequent schedule for long-term management. A healthcare provider will determine the appropriate frequency based on individual factors.

Quick Summary

Humira treatment for Crohn's disease begins with an initial phase involving more frequent administration, followed by a less frequent schedule for ongoing management. The specific frequency varies based on factors such as age and body weight. A healthcare professional establishes the appropriate injection schedule for each patient.

Key Points

  • Ongoing Adult Schedule: Following an initial period, adults typically receive Humira injections every other week for Crohn's management.

  • Initial Treatment Phase: Treatment begins with more frequent administrations to quickly help manage disease activity.

  • Pediatric Administration: The schedule for children aged 6 and older is based on their body weight.

  • Adjustments Possible: If the standard administration frequency becomes less effective, a doctor may recommend adjusting the schedule.

  • Factors Determining Frequency: A doctor considers age, weight, disease severity, response, and other medical factors to determine the best schedule.

  • Administration Training: Patients and caregivers can receive training to administer Humira injections at home, often with the first dose given under medical supervision.

In This Article

Understanding the Humira Treatment Schedule

Humira, with the active ingredient adalimumab, is a biologic medication used to treat moderate to severe Crohn's disease in adults and children 6 years of age and older. It functions by blocking a protein called tumor necrosis factor-alpha (TNF-α), which plays a role in the inflammatory process associated with Crohn's. As an injectable medication, adhering to the prescribed administration schedule is crucial for achieving and maintaining therapeutic effects.

Treatment Frequency for Adults

The typical treatment schedule for adults with Crohn's disease on Humira involves an initial phase designed to rapidly achieve disease control, followed by a less frequent schedule for long-term management.

The Initial Phase

The treatment is initiated with a specific schedule of injections over the first few weeks. This initial period is designed to establish therapeutic levels of the medication in the body to help manage the active symptoms of Crohn's disease.

The Ongoing Management Phase

Following the initial phase, a regular administration schedule is typically followed. This ongoing schedule is designed to maintain control of the disease and help prevent flares. For many adults, this involves injections on a bi-weekly basis.

Treatment Frequency for Pediatric Patients

For children and adolescents aged 6 years and older with Crohn's disease, the administration schedule for Humira is determined based on body weight. This ensures that the appropriate amount of medication is administered for the child's size.

Pediatric Patients Weighing 40 kg or More

The initial and ongoing administration schedules for pediatric patients in this weight range often mirror those of adults.

Pediatric Patients Weighing 17 kg to less than 40 kg

Pediatric patients in this weight category receive a modified administration schedule compared to heavier patients. The frequency of injections in both the initial and ongoing phases is adjusted based on their lower body weight.

Factors Influencing Humira Administration Frequency

While there are standard approaches to Humira administration for Crohn's, several individual factors can influence the optimal frequency of injections. These factors are carefully considered by a healthcare professional to tailor the treatment to each patient's specific needs.

  • Response to Treatment: The patient's response to the medication is a key factor. If the effectiveness of the standard schedule decreases over time, a doctor may consider adjusting the frequency of administration to help maintain disease control. Such adjustments are made based on a clinical evaluation of the patient's condition.
  • Body Weight: As mentioned, body weight is a primary determinant of the administration schedule for pediatric patients. This ensures that the amount of medication is appropriate for their size.
  • Concomitant Medications: The use of other medications concurrently with Humira may sometimes influence the required administration frequency. Your doctor will consider all medications you are taking when determining the Humira schedule.
  • Serum Drug Levels: In some cases, monitoring the level of adalimumab in the blood may provide additional information to guide treatment decisions, although there are ongoing discussions regarding optimal target levels.

Administering Humira Injections: Important Information

Proper administration of Humira is vital for its intended effect. The injections are typically given subcutaneously (under the skin) using a prefilled pen or syringe. Patients and caregivers are often trained by a healthcare professional on the correct injection technique.

  • Injection Site Rotation: To help prevent irritation, it is recommended to rotate the injection site with each dose. Common sites include the front of the thigh and the lower abdomen.
  • First Dose Administration: The initial administration of Humira, particularly for children, is often done under the supervision of a healthcare professional to ensure proper technique and monitor for immediate reactions.
  • Storage Guidelines: Humira should be stored in the refrigerator in its original packaging until it is needed for administration. It should not be frozen.

Comparison of Typical Humira Treatment Schedules for Crohn's

Treatment Phase Adults (≥ 40 kg) Pediatric (17 kg to < 40 kg)
Initial Phase (e.g., Day 1) More frequent administration Modified frequent administration
Initial Phase (e.g., Day 15) More frequent administration Modified frequent administration
Ongoing Management (from Day 29 onwards) Typically every other week Modified every other week

Conclusion

Humira treatment for Crohn's disease involves a structured administration plan that includes an initial period of more frequent injections to achieve control, followed by a less frequent schedule for ongoing management. While a common schedule for adults is administration every other week after the initial phase, the precise frequency for all patients, especially children, is tailored based on factors such as weight and individual response to the medication. It is imperative to work closely with a healthcare provider to establish and follow the most appropriate Humira administration schedule for managing Crohn's disease effectively. Open communication with your doctor is key to optimizing your treatment plan.

For comprehensive information regarding Humira, including detailed administration instructions and potential considerations, consult official prescribing information or reliable pharmaceutical resources under the guidance of a healthcare professional.

Visit Drugs.com for additional information about Humira

Frequently Asked Questions

Following an initial treatment phase, adults with Crohn's disease typically receive Humira injections every other week.

The initial phase for adults involves a schedule with more frequent injections at the beginning of treatment to help gain control of the disease.

Yes, the Humira administration schedule for children (6 years and older) with Crohn's is determined based on their body weight. Children weighing less than 40 kg have a different schedule than adults and heavier pediatric patients.

Yes, if a patient's response to the standard ongoing schedule decreases, a doctor may recommend adjusting the frequency of administration.

If an administration is missed, it should be administered as soon as remembered. If it is close to the time of the next scheduled administration, consult your doctor for guidance. It is important not to administer more than the prescribed amount.

Humira is administered subcutaneously (under the skin) into areas such as the front of the thigh or the abdomen. Rotating the injection site with each administration is advised.

Humira is generally a long-term treatment for managing Crohn's disease, not a cure. The duration of therapy is determined by a healthcare provider based on the patient's condition and response.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.